Announcements Trials
Browse Landscape

Status

Completed 4Recruiting 2

Sponsor Class

OTHER 4

Study Type

Observational 4

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 8Recurrence 4Liver Neoplasms 3Patient Dropouts 1Liver Diseases, Alcoholic 1Fibrosis 1Alcoholism 1

Interventions

Cyclophosphamide 67Dexamethasone 52Peripheral Blood Stem Cell Transplantation 37Lenalidomide 37Rituximab 35fludarabine phosphate 34Bortezomib 30Filgrastim 27Etoposide 27Cytarabine 25Carboplatin 25Busulfan 23Radiotherapy 22Melphalan 22Gemcitabine 22Cyclosporine 21pomalidomide 20fludarabine 20Whole-Body Irradiation 20Mycophenolic Acid 20Paclitaxel 19Methotrexate 18venetoclax 17Cisplatin 17pembrolizumab 16Calcium Dobesilate 16Bevacizumab 16Tacrolimus 14Antilymphocyte Serum 14Nivolumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Recurrence × Liver Transplantation × Clear all
NCT06799468 2025-01-29

TRAIN-AI

European Hepatocellular Cancer Liver Transplant Group

Completed
1,769 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

NCT05200195 2022-06-30

TRAIN-AI

European Hepatocellular Cancer Liver Transplant Group

Completed
4,026 enrolled
Gastrointestinal

Liver Neoplasms, Recurrence

NCT03595345 2018-10-29

TRAIN-SCORE

European Hepatocellular Cancer Liver Transplant Group

Completed
3,100 enrolled
Gastrointestinal

Liver Neoplasms, Patient Dropouts, Recurrence

NCT02898415 2017-09-06

AFP-UTS

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
1,018 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡